EvokeNZ t1_j2v4mr1 wrote on January 4, 2023 at 3:48 AM Reply to Immuno-suppressants may negatively affect SARS-CoV-2 antibody responses. In a study on autoimmune inflammatory rheumatic disease (AIRD) patients, neutralizing antibody levels were significantly lower for AIRD patient than in controls. Arthritis treatments were risk factors for reduced responses by glawgii I thought this was known from the start. In NZ anyone who is immunocompromised is eligible for three primary doses and two boosters. Also advice was given to skip immunosuppressants during the vaccine week. Permalink 37
EvokeNZ t1_j2v4mr1 wrote
Reply to Immuno-suppressants may negatively affect SARS-CoV-2 antibody responses. In a study on autoimmune inflammatory rheumatic disease (AIRD) patients, neutralizing antibody levels were significantly lower for AIRD patient than in controls. Arthritis treatments were risk factors for reduced responses by glawgii
I thought this was known from the start. In NZ anyone who is immunocompromised is eligible for three primary doses and two boosters. Also advice was given to skip immunosuppressants during the vaccine week.